NXGN Share Price Performance
₪0.67
-0.32 (-32.18%)
Price ₪0.67
Share Price₪0.67
NXGN Community Narratives
There are no narratives available yet.
Recent NXGN News & Updates
No updates
Nextgen Biomed Ltd Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.42
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Nextgen Biomed Ltd Competitors
About NXGN
- Founded
- 1990
- Employees
- 3
- CEO
- WebsiteView website
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Israeli Market Performance
- 7 Days: -1.7%
- 3 Months: 18.6%
- 1 Year: 67.6%
- Year to Date: 27.4%
Over the last 7 days, the market has dropped 1.7%, driven by losses in the Financials and Real Estate sectors of 1.8% and 2.9%, respectively. As for the longer term, the market has actually risen by 68% in the last year. Earnings are forecast to grow by 16% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading